Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PGS Browser: a public platform for personalized polygenic score analysis and interpretation.

Nature communications·2026
Same author

Genetic architecture of 67 oral diseases and their links to systemic diseases.

HGG advances·2026
Same author

GWAS Meta-analysis Identifies Novel Associated Loci and Points to Causal Tissues in Central Serous Chorioretinopathy.

medRxiv : the preprint server for health sciences·2026
Same author

Altered neurodevelopmental trajectories of brain structure in Tourette syndrome and Chronic Tic Disorders.

medRxiv : the preprint server for health sciences·2026
Same author

Scalable biological-cognitive profiling for Alzheimer's disease in the population.

Brain communications·2026
Same author

Discovering Age- and Sex-Specific Genetic Risk Factors in Sensorineural Hearing Loss: Genome-Wide Evidence from Large-Scale Biobanks.

Journal of the Association for Research in Otolaryngology : JARO·2026

Related Experiment Video

Updated: Jul 11, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Finding disease candidate genes by liquid association.

Ker-Chau Li1, Aarno Palotie, Shinsheng Yuan

  • 1Department of Statistics, UCLA, 8125 Math Sciences Bldg, Los Angeles, California 90095-1554, USA. kcli@stat.ucla.edu

Genome Biology
|October 5, 2007
PubMed
Summary

A new method uses gene expression data to find potential genes linked to multiple sclerosis (MS). This approach successfully identified several candidate genes associated with MS susceptibility.

More Related Videos

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Related Experiment Videos

Last Updated: Jul 11, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Area of Science:

  • Genetics
  • Bioinformatics
  • Neuroimmunology

Background:

  • Identifying genes associated with complex diseases like multiple sclerosis (MS) is crucial for understanding disease mechanisms.
  • Gene expression data offers a rich resource for discovering novel genetic associations.

Purpose of the Study:

  • To develop and validate a novel computational approach for identifying candidate genes using gene expression data.
  • To apply this method to discover novel susceptibility candidate genes for multiple sclerosis.

Main Methods:

  • Developed a 'liquid association' method to analyze gene expression patterns.
  • Applied the method to publicly available gene expression datasets.
  • Integrated results to identify robust multiple sclerosis susceptibility candidate genes.

Main Results:

  • The liquid association approach effectively identified a set of candidate genes.
  • Several identified genes have plausible biological links to multiple sclerosis pathogenesis.
  • The method demonstrated potential for discovering novel genetic contributors to MS.

Conclusions:

  • The developed liquid association method is a promising tool for candidate gene discovery.
  • This approach can accelerate the identification of genes involved in complex neurological disorders like MS.
  • Further validation of identified candidate genes is warranted.